Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high energy x rays to kill tumor cells. This may be an
effective treatment for prostate cancer. Androgens can cause the growth of prostate cancer
cells. Antihormone therapy, such as goserelin and cyproterone, may lessen the amount of
androgens made by the body and reduces the amount of androgens available to the body. It is
not yet know whether radiation therapy alone is more effective than radiation therapy given
together with goserelin and cyproterone in treating patients with prostate cancer.
PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it
works compared to giving radiation therapy together with goserelin and cyproterone in
treating patients with prostate cancer that is at high risk for metastasis.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC